Eli Lilly & Co. to Acquire AtaiBeckley Inc. for up to $3.8 Billion
Eli Lilly & Co. has agreed to acquire AtaiBeckley Inc. for as much as $3.8 billion, signaling a growing interest from large pharmaceutical companies in the psychedelic medicine sector.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.